Direkt zum Inhalt
Merck
  • Dihydroorotate dehydrogenase Inhibitors Target c-Myc and Arrest Melanoma, Myeloma and Lymphoma cells at S-phase.

Dihydroorotate dehydrogenase Inhibitors Target c-Myc and Arrest Melanoma, Myeloma and Lymphoma cells at S-phase.

Journal of Cancer (2017-09-21)
Mathura Subangari Dorasamy, Bhavesh Choudhary, Kavitha Nellore, Hosahalli Subramanya, Pooi-Fong Wong
PMID28928900
ZUSAMMENFASSUNG

Dihydroorotate dehydrogenase (DHODH) is a rate-limiting enzyme in the

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
X100
Sigma-Aldrich
Triton™ X-100, laboratory grade
P9625
Sigma-Aldrich
Phenazin-Methosulfat
EHU138421
Sigma-Aldrich
MISSION® esiRNA, targeting human DHODH